KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for BioNTech SE (BNTX) over the last 4 years, with Q4 2024 value amounting to $240277.8.

  • BioNTech SE's EPS (Basic) rose 706.68% to $240277.8 in Q4 2024 from the same period last year, while for Dec 2024 it was $240277.8, marking a year-over-year increase of 706.68%. This contributed to the annual value of -$616018.5 for FY2024, which is 1479441186.44% down from last year.
  • According to the latest figures from Q4 2024, BioNTech SE's EPS (Basic) is $240277.8, which was up 706.68% from $241585.4 recorded in Q3 2024.
  • BioNTech SE's EPS (Basic)'s 5-year high stood at $241585.4 during Q3 2024, with a 5-year trough of $81938.8 in Q3 2023.